Literature DB >> 15340872

Re-evaluation of the dysfunction of mitochondrial respiratory chain in skeletal muscle of patients with Parkinson's disease.

K Winkler-Stuck1, E Kirches, C Mawrin, K Dietzmann, H Lins, C-W Wallesch, W S Kunz, F R Wiedemann.   

Abstract

The origin and tissue distribution of the mitochondrial dysfunction in Parkinson's disease (PD) remains still a matter of controversy. To re-evaluate a probably free radical-born, generalized mitochondrial impairment in PD, we applied optimized enzymatic assays, high resolution oxygraphic measurements of permeabilized muscle fibers, and application of metabolic control analysis to skeletal muscle samples of 19 PD patients and 36 age-matched controls. We detected decreased activities of respiratory chain complexes I and IV being accompanied by increased flux control coefficients of complexes I and IV on oxygen consumption of muscle fibers. We further investigated if randomly distributed point mutations in two discrete regions of the mitochondrial DNA are increased in PD muscle, and if they could contribute to the mitochondrial impairment. Our data confirm the previously debated presence of a mild mitochondrial defect in skeletal muscle of patients with PD which is accompanied with an about 1.5 to 2-fold increase of point mutated mtDNA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340872     DOI: 10.1007/s00702-004-0195-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  20 in total

1.  Proteome profile of functional mitochondria from human skeletal muscle using one-dimensional gel electrophoresis and HPLC-ESI-MS/MS.

Authors:  Natalie Lefort; Zhengping Yi; Benjamin Bowen; Brian Glancy; Eleanna A De Filippis; Rebekka Mapes; Hyonson Hwang; Charles R Flynn; Wayne T Willis; Anthony Civitarese; Kurt Højlund; Lawrence J Mandarino
Journal:  J Proteomics       Date:  2009-06-28       Impact factor: 4.044

2.  Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease.

Authors:  Neil A Kelly; Matthew P Ford; David G Standaert; Ray L Watts; C Scott Bickel; Douglas R Moellering; S Craig Tuggle; Jeri Y Williams; Laura Lieb; Samuel T Windham; Marcas M Bamman
Journal:  J Appl Physiol (1985)       Date:  2014-01-09

3.  Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle.

Authors:  Alethea G Barschak; Gustavo da C Ferreira; Karina R André; Patrícia F Schuck; Carolina M Viegas; Anelise Tonin; Carlos S Dutra Filho; Angela T S Wyse; Clóvis M D Wannmacher; Carmen R Vargas; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2006-04-28       Impact factor: 3.584

Review 4.  Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease.

Authors:  Maryam Abrishamdar; Maryam Sadat Jalali; Yaghoob Farbood
Journal:  Cell Mol Neurobiol       Date:  2022-08-11       Impact factor: 4.231

Review 5.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

6.  Do mtDNA Mutations Participate in the Pathogenesis of Sporadic Parkinson's Disease?

Authors:  E Kirches
Journal:  Curr Genomics       Date:  2009-12       Impact factor: 2.236

7.  Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity.

Authors:  Vladimir B Ritov; Elizabeth V Menshikova; Koichiro Azuma; Richard Wood; Frederico G S Toledo; Bret H Goodpaster; Neil B Ruderman; David E Kelley
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-03       Impact factor: 4.310

Review 8.  Mitochondrial dynamics in Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Exp Neurol       Date:  2009-03-28       Impact factor: 5.330

9.  Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease.

Authors:  Pilar del Hoyo; Alberto García-Redondo; Fernando de Bustos; José Antonio Molina; Youssef Sayed; Hortensia Alonso-Navarro; Luis Caballero; Joaquín Arenas; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2010-10-19       Impact factor: 2.474

10.  Mitochondrial serine protease Omi/HtrA2 accentuates brain ischemia/reperfusion injury in rats and oxidative stress injury in vitro by modulating mitochondrial stress proteins CHOP and ClpP and physically interacting with mitochondrial fusion protein OPA1.

Authors:  Hailong You; Yao Jin; Jinsong Kang; Ying Mao; Jing Su; Liankun Sun; Li Wang; Hao Meng
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.